Showing results (231-240 of 368) with videos related to
Sort By:
Pageof 37
JACC. Cardiooncology|November 16, 2023
Cardiotoxicity of BRAF/MEK Inhibitors: A Longitudinal Study Incorporating Contemporary Definitions and Risk ScoresClaire Glen, Sarah Adam, Kirsty McDowell, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 27, 2000
The patterns of expression of an apoptosis-related CK18 neoepitope, the bcl-2 proto-oncogene, and the Ki67 proliferation marker in normal, hyperplastic, and malignant endometriumH M Morsi, M P Leers, W Jäger, et al.Heart and Vessels|March 12, 2011
Vasomotor and fibrinolytic responses to kinin receptor agonists in the atherosclerotic human lower limbNicholas L M Cruden, Ninian N Lang, Thomas J MacGillivray, et al.JACC. Cardiooncology|May 2, 2022
Mechanistic and Clinical Overview Cardiovascular Toxicity of BRAF and MEK Inhibitors: JACC: CardioOncology State-of-the-Art ReviewClaire Glen, Yun Yi Tan, Ashita Waterston, et al.Cancer Gene Therapy|September 27, 2008
Intravenous injection of siRNA directed against hypoxia-inducible factors prolongs survival in a Lewis lung carcinoma cancer modelF Kamlah, B G Eul, S Li, et al.Intensive Care Medicine Experimental|June 17, 2020
Use of the CytoSorb adsorption device in MDMA intoxication: a first-in-man application and in vitro studyCorinna N Lang, Michaela J Sommer, Merja A Neukamm, et al.BMJ Open|August 31, 2021
Pulmonary thromboembolism in hospitalised patients with COVID-19: a retrospective national study of patients managed in critical care and ward environments in ScotlandMichael McGettrick, Alexander MacLellan, Paul McCaughey, et al.BMC Emergency Medicine|December 8, 2020
Lung ultrasound in the emergency department - a valuable tool in the management of patients presenting with respiratory symptoms during the SARS-CoV-2 pandemicBonaventura Schmid, Doreen Feuerstein, Corinna N Lang, et al.Journal of Cardiovascular Pharmacology|November 27, 2008
Vascular B1 kinin receptors in patients with congestive heart failureNinian N Lang, Nicholas L Cruden, George H Tse, et al.JACC. Cardiooncology|May 22, 2024
Cardiovascular Eligibility Criteria and Adverse Event Reporting in Combined Immune Checkpoint and VEGF Inhibitor TrialsStephen Rankin, Benjamin Elyan, Robert Jones, et al.Pageof 37